| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
1e-09 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
3e-09 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.25 |
3e-09 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
1e-07 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
2e-07 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-07 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-07 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
4e-07 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
4e-07 |
| mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
4e-07 |